1-20 of 893
Immunobiology and Immunotherapy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL

Open Access
Clinical Trials & Observations
Rakesh Awasthi, Stephan A. Grupp, Edward R. Waldron, Gregory A. Yanik, Constantine S. Tam, Susana Rives, Joseph P. McGuirk, Michael A. Pulsipher, Ulrich Jaeger, Gary D. Myers, Peter Borchmann, Stephen J. Schuster, Heather E. Stefanski, Michael R. Bishop, Abhijit Chakraborty, Aisha Masood, André Baruchel, Edmund K. Waller
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4405–4414.
https://doi.org/10.1182/bloodadvances.2024014995
Published: 2025
Includes: Supplemental data
Journal Articles

Harnessing Viral-Specific T Cells: Expanding Therapeutic Strategies Across Diverse Populations

Open Access
Navid Djassemi, Benjamin Hanisch, Cecilia Motta, Naseem Maghzian, Anant Vatsayan, Jessica R Durkee-Shock, Michael D. Keller
Journal: Blood Advances
Blood Adv bloodadvances.2024013727.
https://doi.org/10.1182/bloodadvances.2024013727
Published: 2025
Includes: Supplemental data
Journal Articles

Peripheral neuropathy and BTKis in Waldenström: a response?

Open Access
Chiara Briani, Bruno Ferrero, Alessandro Salvalaggio, Simone Ragaini, Enrico Amaducci, Irene Dogliotti, Andrea Visentin, Simone Ferrero
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4319–4320.
https://doi.org/10.1182/bloodadvances.2025016734
Published: 2025
Journal Articles

IGSF9-targeted therapy inhibits the progression of acute myeloid leukemia

Open Access
Lijun Hui, Jing Xiao, Zhiling Zhao, Juan Zhang, Huiwen Luan, Jiashen Zhang, Yuxiao Sun, Xianhui Meng, Hongying Wang, Chunling Li, Fangmin Li, Shuhao Ji, Shuping Wei, Fang Li, Hong Yu, Chengyun Zheng, Yang Jiang, Yaopeng Wang, Zunling Li
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4217–4231.
https://doi.org/10.1182/bloodadvances.2025016432
Published: 2025
Includes: Supplemental data
Journal Articles

Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma

Open Access
Xavier Deschênes-Simard, Maria Bromberg, Sean M. Devlin, Mithat Gonen, Ofrat Beyar-Katz, Andrew Ip, Ronit Marcus, Abraham Avigdor, Annamaria Ballweg, Emma Rabinovich, Mohammad Alhomoud, Alfredo Rivas-Delgado, Magdalena Corona De Lapuerta, Alejandro Luna De Abia, M. Lia Palomba, Gunjan L Shah, Richard J. Lin, Alexander P Boardman, Lorenzo Falchi, Jennifer K Lue, Gilles A. Salles, Miguel-Angel Perales, Roni Shouval, Parastoo B. Dahi, Michael Scordo
Journal: Blood Advances
Blood Adv bloodadvances.2025016778.
https://doi.org/10.1182/bloodadvances.2025016778
Published: 2025
Includes: Supplemental data
Journal Articles

Avoid burning bridges before CAR-T therapy in myeloma

Open Access
Swetha Reddi, Rahul Banerjee
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4232–4234.
https://doi.org/10.1182/bloodadvances.2025016774
Published: 2025
Journal Articles

Bridging intensity is associated with impaired hematopoietic recovery after BCMA CAR-T therapy for multiple myeloma

Open Access
Jan H. Frenking, Xiang Zhou, Kai Rejeski, Vivien Wagner, Patrick Costello, Thomas Hielscher, Lilan Gatti, Joseph Kauer, Omar Nadeem, Elias K. Mai, Christian S. Michel, Mirco J. Friedrich, David Sedloev, Niels Weinhold, Hartmut Goldschmidt, Klaus Herfarth, Anita Schmitt, Michael Hundemer, Michael Schmitt, Carsten Müller-Tidow, Max Topp, Hermann Einsele, Peter Dreger, Nikhil C. Munshi, Adam S. Sperling, Leo Rasche, Sandra Sauer, Marc S. Raab
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4151–4166.
https://doi.org/10.1182/bloodadvances.2024015732
Published: 2025
Includes: Supplemental data
Journal Articles

Invasive fungal disease is rare in patients with relapsed/refractory multiple myeloma treated with BCMA CAR T-cell therapy

Open Access
Clinical Trials & Observations
Jessica S. Little, Angelica Medina Pena, E. Bridget Kim, Andrew J. Yee, Omar Nadeem, Shonali Midha, Adam S. Sperling, Nikhil C. Munshi, Noopur Raje, Matthew J. Frigault, Diana D. Cirstea, Sarah P. Hammond
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4190–4194.
https://doi.org/10.1182/bloodadvances.2025016748
Published: 2025
Includes: Supplemental data
Journal Articles

A patient-derived CABIN1 mutation recapitulates features of idiopathic multicentric Castleman disease in a mouse model

Open Access
Dorottya Laczko, Patricia Y. Tsao, Ruth-Anne Pai, Joseph Zinski, Michael V Gonzalez, Melanie Mumau, Tobias D Raabe, Hiromi Muramatsu, Norbert Pardi, Taku Kambayashi, David C. Fajgenbaum
Journal: Blood Advances
Blood Adv bloodadvances.2025016749.
https://doi.org/10.1182/bloodadvances.2025016749
Published: 2025
Includes: Supplemental data
Journal Articles

Allogeneic hematopoietic stem cell transplantation for STAT3 hyper-IgE syndrome: a worldwide study

Open Access
Christo Tsilifis, Johannes Raedler, Joanna Renke, Michael Medinger, Alexandra Laberko, Ásgeir Haraldsson, Niraj Patel, Peter Ciznar, Melanie Wong, Steven J. Keogh, Paul Gray, Richard Mitchell, Venetia Bigley, Suzanne Elcombe, Fabian Hauck, Michael H. Albert, Eleni Tholouli, Archana Herwadkar, Shuayb Elkhalifa, Chris Kosmidis, Giorgio Callisti, Lauri M. Burroughs, Karin Chen, Ben Carpenter, Thomas A. Fox, Emma C. Morris, Ramya Uppuluri, Revathi Raj, Masakatsu Yanagimachi, Emilie P. Buddingh, Christina Oikonomopoulou, Corina Gonzalez, Dimana Dimitrova, Jennifer A. Kanakry, Danielle Arnold, Sung-Yun Pai, Mary A. Slatter, Mark S. Pearce, Austen Worth, Alexandra F. Freeman, Andrew R. Gennery
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4126–4135.
https://doi.org/10.1182/bloodadvances.2025016158
Published: 2025
Includes: Supplemental data
Journal Articles

Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvement

Open Access
Ibrahim N. Muhsen, Gregory W. Roloff, Rawan Faramand, Tamer Othman, Yannis Valtis, Noam E. Kopmar, Simone E. Dekker, Matthew Connor, Santiago Mercadal, Timothy E. O'Connor, Kaitlyn C. Dykes, Mohamed Ahmed, Nikeshan Jeyakumar, Amy Zhang, Katharine Miller, Katherine C. Sutherland, Caitlin Guzowski, Vishal K. Gupta, Navneet Majhail, Minoo Battiwalla, Melhem M. Solh, Shahbaz A. Malik, John Mathews, Caspian H. Oliai, Paul Shaughnessy, Luke Mountjoy, Catherine J. Lee, Aaron C. Logan, Stephanie B. Tsai, Jessica T. Leonard, Marc Schwartz, Joshua P. Sasine, Muthu Kumaran, Noelle Frey, Jae H. Park, Divya Koura, Ryan D. Cassaday, Bijal D. Shah, Ibrahim Aldoss, Lori S. Muffly, LaQuisa C. Hill
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4081–4089.
https://doi.org/10.1182/bloodadvances.2024015779
Published: 2025
Journal Articles

Exorcizing the devil of factor VIII inhibitors

Open Access
Paul C. Moorehead
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3716–3717.
https://doi.org/10.1182/bloodadvances.2025016643
Published: 2025
Journal Articles

Outcomes in frail patients receiving BCMA-directed bispecific antibodies for relapsed/refractory multiple myeloma

Open Access
Benjamin Adegbite, Carlyn Rose Tan, Tala Shekarkhand, Ross S. Firestone, Eric M. Jurgens, Kevin Miller, Alexander M. Lesokhin, Gunjan L. Shah, Neha Korde, Sridevi Rajeeve, Heather J. Landau, Michael Scordo, Hani Hassoun, Kylee H. Maclachlan, Urvi A. Shah, Malin Hultcrantz, Issam S. Hamadeh, Andriy Derkach, David Nemirovsky, Sergio A. Giralt, Sham Mailankody, Saad Z. Usmani, Hamza Hashmi
Journal: Blood Advances
Blood Adv (2025) 9 (15): 4016–4022.
https://doi.org/10.1182/bloodadvances.2025015973
Published: 2025
Journal Articles

Single-cell sequencing on PBMCs from patients with HA and HB with inhibitors reveals different immune responses to FVIII and FIX

Open Access
Enhao Li, Zekun Li, Jinzeng Wang, Haoyang Wu, Yilun Xue, Can Lou, Zhenping Chen, Feng Liu, Wenman Wu, Qiulan Ding, Runhui Wu, Xuefeng Wang, Jing Dai
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3967–3978.
https://doi.org/10.1182/bloodadvances.2025015799
Published: 2025
Includes: Supplemental data
Journal Articles

Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR Analysis

Open Access
Hemalatha G. Rangarajan, Prakash Satwani, Megan M. Herr, Min Chen, Michael J. Martens, Kitsada Wudhikarn, Samuel John, Vanessa A. Fabrizio, Emily M. Hsieh, Amar H. Kelkar, Erin Doherty, David I. Marks, Olle Ringden, Brian D. Friend, Matthew S. Kelly, Nosha Farhadfar, Timothy Prestidge, Nasheed M. Hossain, Hongtao Liu, Shahrukh Hashmi, Dipenkumar Modi, Lena E. Winestone, Zeinab El Boghdadly, Hemant S. Murthy, Miguel-Angel Perales, Roy F. Chemaly, Christopher E. Dandoy, Joshua A. Hill, Anna R. Huppler, Marcie Riches, Jeff J. Auletta
Journal: Blood Advances
Blood Adv bloodadvances.2025016149.
https://doi.org/10.1182/bloodadvances.2025016149
Published: 2025
Includes: Supplemental data
Journal Articles

Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study

Open Access
Clinical Trials & Observations
Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff, Meng Wang, Thomas Melchardt, Udo Holtick, Ulrike Bacher, Philipp Staber, Paolo Mazzeo, Corinna Leng, David Böckle, Alexander Hölscher, Joseph Kauer, Natalia Rotter, Vladan Vucinic, Jakob Rudzki, David Nachbaur, Veit Bücklein, Ulf Schnetzke, Isabelle Krämer, Kai Wille, Alexander Hasse, Bastian von Tresckow, Mathias Hänel, Christian Koenecke, Giuliano Filippini Velazquez, Andreas Viardot, Christoph Schmid, Lorenz Thurner, Dominik Wolf, Marion Subklewe, Martin Dreyling, Peter Dreger, Sascha Dietrich, Ulrich Keller, Ulrich Jäger, Richard Greil, Thomas Pabst, Georg Lenz, Björn Chapuy
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3865–3877.
https://doi.org/10.1182/bloodadvances.2024014903
Published: 2025
Includes: Supplemental data
Journal Articles

Targeting S100A9-mediated inflammation: A novel therapeutic approach for CLL

Open Access
Angimar Uriepero-Palma, Maria Elena Marquez, Dr., Eugenia Payque, Melanie Mediavilla-Varela, Wael Gamal, Kamira Maharaj, John J Powers, Erika Adriana Eksioglu, Julio C. Chavez, Sandra Sernbo, Florencia Palacios, Juliana Querol Rivas, Claudia Ortega, Rita Uria, Gimena dos Santos, Carolina Oliver, Ana Ines Landoni, Dra, Eva Sahakian, Pablo Oppezzo, Javier Pinilla-Ibarz
Journal: Blood Advances
Blood Adv bloodadvances.2025016061.
https://doi.org/10.1182/bloodadvances.2025016061
Published: 2025
Includes: Supplemental data
Journal Articles

Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy

Open Access
Snegha Ananth, Nancy Eunice Torres, Bita Sahaf, Lekha Mikkilineni, Sebastian Fernandez-Pol, Darren Salmi, Robert Negrin, Parveen Shiraz, Melody Smith, Sushma Bharadwaj, Wen-Kai Weng, Vanessa E. Kennedy, Saurabh Dahiya, Lori Muffly, David Miklos, Matthew J. Frank, Hitomi Hosoya, Surbhi Sidana
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3832–3836.
https://doi.org/10.1182/bloodadvances.2025016346
Published: 2025
Includes: Supplemental data
Journal Articles

HLA-E[pHLA-G] Complex Specific Monoclonal Antibody Enhancing NK Activity in Multiple Myeloma

Open Access
Muhammad Abu Ahmad, Olga Radinsky, Bar Kaufman, Kamran Waidha, Eman Gharra, Sharon Dim, Dinesh Babu Manikandan, Noa Ofir, Dirk Jäger, Marten Meyer, Moshe Elkabets, Kerry S. Campbell, Miri Zektser, Roi Gazit, Ory Rouvio, Frank Momburg, Angel Porgador
Journal: Blood Advances
Blood Adv bloodadvances.2025016276.
https://doi.org/10.1182/bloodadvances.2025016276
Published: 2025
Includes: Supplemental data
Journal Articles

T-cell dysfunction during blinatumomab therapy in pediatric acute lymphoblastic leukemia

Open Access
Julie Ma, Annie Luong, Andrew Doan, Tsen Yin Lin, Lingyun Ji, Cassandra P. Wang, Seon-Jae Yoon, Teresa Rushing, Anh Duong, Miguel Villa, Chintan Parekh
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3689–3693.
https://doi.org/10.1182/bloodadvances.2025015894
Published: 2025
Includes: Supplemental data